Skip to content

Galt Pharmaceuticals is a unique pharmaceutical company that develops and commercializes prescription medications that help satisfy the unmet clinical needs of many patient types. 

ABOUT GALT PHARMACEUTICALS

In Ayn Rand’s 1957 novel Atlas Shrugged, the inspirational John Galt believes an individual with strong will and work ethic can overcome any obstacle and achieve their objective(s). We were named after John Galt who represents the pursuit of a better way, a shared core value with us. Our better way is a unique model of delivering pharmaceutical care to enhance the lives of patients and the people who care for them.

We believe this better way will enhance the quality of life of patients through products which satisfy unmet clinical needs, while supporting patient-centric partnerships with healthcare providers in the communities we serve. Galt’s founders believe there’s a better way to pharmaceutical care than provided by traditional big pharma. At Galt Pharmaceuticals, education to healthcare providers is delivered through collaborative and personalized account management – involving all in the medical practice contributing to patient care. We only work with healthcare practices that share our vision of patient centricity and the commitment of every patient receiving the medication they were prescribed.

GALT'S PILLARS

Galt enhances quality of life of patients with medications that answer unmet needs with little or no out-of-pocket expenses for those drugs. Galt leverages business intelligence to identify, develop and bring high-value pharmaceutical products to market through a unique approach: Pharmaceutical Phranchising.

PATIENTS

Galt enhances quality of life of patients with medications that answer unmet needs with little or no out-of-pocket expenses for those drugs. Galt leverages business intelligence to identify, develop and bring high-value pharmaceutical products to market through a unique approach.

ENTREPRENEUERS

Galt enhances the lives of entrepreneurs and their families with the life-changing opportunity to own a business in an industry with traditionally high barriers of entry. Through our partnership with Galt Phranchise Systems, www.galtps.com we are able to empower hard-working business-minded people to build and own their own enterprise around a growing portfolio of needed medications coupled with community relationships, trust and exceptional personalized service.

EMPLOYEES

Galt enhances the lives of employees by rewarding them for their support in building the dreams of entrepreneurs. Galt recognizes the importance of committed employees when supporting entrepreneurial-driven businesses.

COMMUNITIES

Galt enhances lives in the communities it serves through the support of hard-working individuals and deserving small businesses or non-profit organizations.

LEADERSHIP TEAM

Galt has assembled a highly motivated and experienced leadership team that has been uniquely put together based on the growth needs of our distinct business model.

Wade Smith Pharm.D., PhD

Chairman and Co-Founder

ceo, co-founder

Barry Patel Pharm.D.

CEO and Co-Founder

chief operating officer

Anna Claire Fry

Chief Operating Officer

head of regulatory galt

Manoj Amaraneni

Chief Regulatory Officer

company controller

Brian Imperiale

Controller

BUSINESS DEVELOPMENT

Galt is actively seeking to bring innovative medicines to more patients through our unique business model and this drives our business development strategy.
Our vision for the future focuses on the licensing, partnering and acquisition of marketed and development-stage medicines to accelerate our growth in various therapeutic areas with high unmet treatment needs. Our business development team is constantly looking for new opportunities and via a diversified approach is able to make strategic deals that benefit our patients, our partners and our phranchisees. Please contact us at bd@galtrx.com for inquiries.

Wade Smith, Chairman and Co-Founder

Wade’s career in healthcare spans over thirty years, with a pronounced leadership presence in the pharmaceutical sector, particularly in forging business development partnerships and navigating the complexities of drug commercialization in challenging markets. His journey encompasses a broad spectrum of roles from clinical pharmacy to strategic leadership positions in both medium-sized and large pharmaceutical corporations, culminating in the co-founding and successful exit of a pharma startup. Beyond the pharmaceutical industry, Wade’s expertise extends into executive leadership roles within a national Pharmacy Benefit Manager (PBM) and a regional Health Maintenance Organization (HMO), which was later integrated into United Health Care.
Wade’s entrepreneurial spirit and keen insight into market dynamics have been pivotal in identifying and overcoming entry barriers, fostering resilience, and mentoring emerging talents in the pharmaceutical landscape. With a wealth of experience in payer relations and commercial pharmaceutical strategies, he played an instrumental role in establishing Galt Pharmaceuticals, marking a new chapter in his commitment to innovation in healthcare.
Holding a Doctor of Pharmacy (PharmD) from Mercer University, an MBA from Vanderbilt University, and a PhD from the University of Louisiana at Monroe, where his dissertation delved into a Constructivist Approach to resolving dilemmas, Wade’s academic achievements mirror his professional ethos.

Barry Patel, CEO and Co-Founder

Barry exemplifies healthcare entrepreneurship, bringing over three decades of comprehensive business experience that spans the pharmaceutical, managed care, outcomes research, and quality improvement sectors of healthcare. His career began with a solid foundation in Clinical Research and Medical Affairs within the pharmaceutical industry, setting the stage for an entrepreneurial journey.
Demonstrating a keen eye for innovation and a passion for enhancing healthcare delivery, Barry co-founded Total Therapeutic Management (TTM). This pioneering venture focused on outcomes research and provider engagement, offering data-driven Quality Improvement services that positioned TTM as a beacon in the healthcare quality improvement and outcomes research fields. The success and industry recognition of TTM culminated in its acquisition by a leading global entity in healthcare solutions in 2014.
Building on his extensive experience and leveraging his expertise across various healthcare domains, Barry ventured into co-founding Galt Pharmaceuticals. This endeavor was driven by his commitment to addressing unmet needs in the healthcare sector through innovative solutions. Barry’s educational background includes a Doctorate in Pharmacy from Mercer University, Atlanta, following his undergraduate studies at the University of Georgia. He continues to contribute to the academic field as an adjunct professor in the Department of Pharmacy Practice at Mercer University.

Anna Claire Fry, Chief Operating Officer

With a seasoned background in information systems, Anna Claire stands at the forefront of operational leadership within Galt, masterfully weaving together IT solutions and operational strategies. Her tenure at Pariveda Solutions, marked by a focus on software development, saw her tackle complex technological challenges across diverse projects and sectors. Anna Claire’s expertise is further underscored by her adeptness in Agile Methodology, a testament to her project management prowess and her ability to adapt and innovate in fast-paced environments.
Anna Claire’s insatiable drive for knowledge equips her with the unique capability to swiftly decipher business hurdles and architect IT solutions that not only solve immediate issues but also streamline operations for scalability and efficiency. At the helm of Galt’s enterprise systems, she orchestrates the seamless integration of data management throughout the spectrum of commercial operations, corporate infrastructure, regulatory compliance, and franchise networks.
Her educational foundation, with a Bachelor’s in Management Information Systems and a Master’s in Operations Management specializing in Enterprise Integration from the University of Alabama, provides a solid bedrock for her role. She now serves as a corporate member for the UA MIS Advisory Board.

Manoj Amaraneni, Chief Regulatory Officer

Manoj Amaraneni stands at the forefront of regulatory excellence within Galt Pharmaceuticals, wielding an impressive track record in navigating the complex terrain of FDA regulations with a dynamic leadership role in regulatory affairs and pharmacovigilance. His profound expertise extends through the intricate processes of regulatory agency engagements, IND, NDA, ANDA, and PAS filings, culminating in successful approvals that underscore his adeptness in the field.
A seasoned leader, Manoj’s comprehensive understanding of the regulatory framework encompasses the full spectrum of clinical development, lifecycle management, and post-approval phases, including phase IV studies, pharmacovigilance, and supplemental approvals. His strategic vision and operational acumen are pivotal in aligning Galt’s clinical development, quality assurance, and regulatory compliance initiatives, ensuring a seamless dialogue with the FDA to expedite the introduction of innovative products.
Driven by a commitment to fulfill unmet medical needs, Manoj leverages his insights to guide the discovery and development of safe, clinically effective treatments that resonate with patient needs. His academic foundation, rooted in a Bachelor’s degree in Pharmacy from India and further enriched by a Master’s in Regulatory Affairs and a PhD in Toxicology from the University of Georgia, forms the bedrock of his professional ethos. A distinguished member of the Regulatory Affairs Professionals Society (RAPS) and holding RAC (US) certification from the Regulatory Affairs Certification Board, Manoj’s leadership is instrumental in steering Galt Pharmaceuticals through the evolving regulatory landscape, ensuring the delivery of new, impactful medical solutions.

Brian Imperiale, Controller

Brian has distinguished himself as a pivotal leader at Galt Pharmaceuticals, bringing over four decades of comprehensive experience, with more than 25 of those years dedicated to spearheading financial reporting, risk management, and operational excellence. Renowned for his strategic contributions during challenging fiscal periods, Brian has been instrumental in implementing process enhancements that have dramatically slashed costs, fostering a culture of mentorship and development among his staff, and playing a critical role in securing capital and navigating through complex acquisition deals.
Since joining Galt at the onset of 2021, Brian has served as the linchpin in the company’s financial stewardship as the Controller. His tenure is marked by the meticulous refinement of processes and the fortification of internal controls, establishing a framework of rigorous financial discipline and reporting that has become the backbone of Galt’s financial operations.